Novo Nordisk plunges following latest CagriSema data
-- Novo Nordisk’s stock has dropped around 6.6% in premarket trading Monday following the release of its latest clinical trial data for CagriSema, a treatment for...
-- Novo Nordisk’s stock has dropped around 6.6% in premarket trading Monday following the release of its latest clinical trial data for CagriSema, a treatment for...
BERLIN (Reuters) - More than half a million people are facing travel disruption at German airports on Monday where a 24-hour strike has led to thousands of flight cancellations in...
-- Citi has lowered its estimates for Apple's (NASDAQ:AAPL) iPhone sales, citing delays in a key Siri upgrade originally planned for April. The bank now expects...
-- Holcim (SIX:HOLN) has been downgraded to “neutral” from “buy,” by Citi Research, as analysts conclude that the stock has largely priced in its sum-of-the-parts...
-- Shares of Mineralys Therapeutics (NASDAQ:MLYS) surged 43% today following the announcement of positive topline results from its Launch-HTN and Advance-HTN trials...
(Reuters) - British shares fell on Monday as worries about global growth and uncertainties around U.S. tariffs continued to keep investors on edge. The blue-chip FTSE 100 lost...
-- Goldman Sachs analysts project that S&P 500 dividends will grow by 6% year-over-year in 2025, despite recent market volatility. “We forecast S&P 500 dividend...
-- Shares of Beam Therapeutics Inc. (Nasdaq: BEAM) surged 15% following the announcement of encouraging initial data from the Phase 1/2 trial of its BEAM-302...
-- U.S. stocks are more sensitive to changes in economic growth than to moves in Treasury yields, according to Lori Calvasina, head of U.S. equity strategy at RBC...
-- Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI) surged 32% following the announcement of positive topline results from their Phase 2a RIVER trial of Haduvio. The...